Moxetumomab Pasudotox-tdfk and Propranolol Sustained-Release Capsules
Determining the interaction of Moxetumomab Pasudotox-tdfk and Propranolol Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: propranolol
Brand name: Hemangeol, Inderal LA, Inderal XL, InnoPran XL, Inderal, InnoPran XL
Synonyms: Propranolol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Propranolol Tablets
- Moxetumomab Pasudotox-tdfk-Proprinal
- Moxetumomab Pasudotox-tdfk-Propulsid
- Moxetumomab Pasudotox-tdfk-Propulsid (Cisapride Suspension)
- Moxetumomab Pasudotox-tdfk-Propulsid (Cisapride Tablets)
- Moxetumomab Pasudotox-tdfk-Propylhexedrine
- Propranolol Sustained-Release Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Propranolol Sustained-Release Capsules-Moxifloxacin
- Propranolol Sustained-Release Capsules-Moxifloxacin (Systemic)
- Propranolol Sustained-Release Capsules-Moxifloxacin Hydrochloride
- Propranolol Sustained-Release Capsules-Moxifloxacin Injection
- Propranolol Sustained-Release Capsules-Moxifloxacin Intravenous